Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 25 results.
User Information
Export Records
  1. 1.   Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population
  2. Petersen, D. C.; Glashoff, R. H.; Shrestha, S.; Bergeron, J.; Laten, A.; Gold, B.; van Rensburg, E. J.; Dean, M.; Hayes, V. M.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 15; 40(5): 521-526.
  1. 2.   Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems
  2. Zhang, N.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2005, DEC; 78(6): 1210-1214.
  1. 3.   The case for selection at CCR5-Delta 32
  2. Sabeti, P. C.; Walsh, E.; Schaffner, S. F.; Varilly, P.; Fry, B.; Hutcheson, H. B.; Cullen, M.; Mikkelsen, T. S.; Roy, J.; Patterson, N.; Cooper, R.; Reich, D.; Altshuler, D.; O'Brien, S.; Lander, E. S.
  3. Plos Biology. 2005, NOV; 3(11): 1963-1969.
  1. 4.   Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking
  2. Chen, X.; Murakami, T.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Blood. 2005, OCT 1; 106(7): 2409-2416.
  1. 5.   Ligand-induced partitioning of human CXCR1 chemokine receptors with lipid raft microenvironments facilitates G-protein-dependent signaling
  2. Jiao, X. M.; Zhang, N.; Xu, X. H.; Oppenheim, J. J.; Jin, T.
  3. Molecular and Cellular Biology. 2005, JUL; 25(13): 5752-5762.
  1. 6.   Autoantigens act as tissue-specific chemoattractants
  2. Oppenheim, J. J.; Dong, H. F.; Plotz, P.; Caspi, R. R.; Dykstra, M.; Pierce, S.; Martin, R.; Carlos, C.; Finn, O.; Koul, O.; Howard, O. M. Z.
  3. Journal of Leukocyte Biology. 2005, JUN; 77(6): 854-861.
  1. 7.   Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate
  2. Howard, O. M. Z.; Dong, H. F.; Su, S. B.; Caspi, R. R.; Chen, X.; Plotz, P.; Oppenheim, J. J.
  3. Blood. 2005, JUN 1; 105(11): 4207-4214.
  1. 8.   Dendritic cells endocytose Bacillus anthracis spores: Implications for anthrax pathogenesis
  2. Brittingham, K. C.; Ruthel, G.; Panchal, R. G.; Fuller, C. L.; Ribot, W. J.; Hoover, T. A.; Young, H. A.; Anderson, A. O.; Bavari, S.
  3. Journal of Immunology. 2005, MAY 1; 174(9): 5545-5552.
  1. 9.   Autoantigens interact with chemokine receptors: Uveitis antigens induce CXCR3 and CXCR5 expressing lymphocytes and immature dendritic cells to migrate
  2. Howard, O. M. Z.; Dong, H. F.; Su, S. B.; Caspi, R. R.; Chen, X.; Plotz, P.; Oppenheim, J. J.
  3. Faseb Journal. 2005, MAR 7; 19(5, Part 2, Suppl. S): A1416-A1416.
  1. 10.   The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users
  2. Duggal, P.; Winkler, C. A.; An, P.; Yu, X. F.; Farzadegan, H.; O'Brien, S. J.; Beaty, T. H.; Vlahov, D.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005 38(5): 584-589.
  1. 11.   Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5
  2. Lederman, M. M.; Veazey, R. S.; Offord, R.; Mosier, D. E.; Dufour, J.; Mefford, M.; Piatak, M.; Lifson, J. D.; Salkowitz, J. R.; Rodriguez, B.; Blauvelt, A.; Hartley, O.
  3. Science. 2004, OCT 15; 306(5695): 485-487.
  1. 12.   Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo
  2. Biragyn, A.; Ruffini, P. A.; Coscia, M.; Harvey, L. K.; Neelapu, S. S.; Baskar, S.; Wang, J. M.; Kwak, L. W.
  3. Blood. 2004, OCT 1; 104(7): 1961-1969.
  1. 13.   An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells
  2. Puri, A.; Rawat, S. S.; Lin, H. M. J.; Finnegan, C. A.; Mikovits, J.; Ruscetti, F. W.; Blumenthal, R.
  3. Aids. 2004 18(6): 849-858.
  1. 14.   Fraction of cases of acquired immunodeficiency syndrome prevented by the interactions of identified restriction gene variants
  2. Silverberg, M. J.; Smith, M. W.; Chmiel, J. S.; Detels, R.; Margolick, J. B.; Rinaldo, C. R.; O'Brien, S. J.; Munoz, A.
  3. American Journal of Epidemiology. 2004 159(3): 232-241.
  1. 15.   Up-regulated expression and activation of the. orphan chemokine receptor, CCRL2, in rheumatoid arthritis
  2. Galligan, C. L.; Matsuyama, W.; Matsukawa, A.; Mizuta, H.; Hodge, D. R.; Howard, O. M. Z.; Yoshimura, T.
  3. Arthritis and Rheumatism. 2004 50(6): 1806-1814.
  1. 16.   Ligand-induced partitioning of human CXCR1 chemokine receptors with lipid-raft microenvironments facilitates G-protein-dependent signaling
  2. Jiao, X.; Zhang, N.; Xu, X.; Oppenheim, J. J.; Jin, T.
  3. Molecular Biology of the Cell. 2004 15(2383, Suppl. S): 430A-430A.
  1. 17.   Some tumor antigens, like autoantigens, are chemotactic for mononuclear cells and utilize chemokine receptors
  2. Howard, O. M. Z.; Dong, H. F.; Robbins, P. F.; Carlos, C.; Finn, O.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2004 (Suppl. S): 19-20.
  1. 18.   Action of Anti-HIV drugs and resistance: Reverse transcriptase inhibitors and protease inhibitors
  2. Imamichi, T.
  3. Current Pharmaceutical Design. 2004 10(32): 4039-4053.
  1. 19.   Patterns of ethnic diversity among the genes that influence AIDS
  2. Winkler, C.; An, P.; O'Brien, S. J.
  3. Human Molecular Genetics. 2004 13(Sp. Iss. 1): R9-R19.
  1. 20.   An expanding appreciation of the role chemokine receptors play in cancer progression
  2. Howard, O. M. Z.; Galligan, C. L.
  3. Current Pharmaceutical Design. 2004 10(19): 2377-2389.
  1. 21.   Update on D-Ala-Peptide T-Amide (DAPTA): A viral entry inhibitor that blocks CCR5 chemokine receptors
  2. Ruff, M. R.; Polianova, M.; Yang, Q. E.; Leoung, G. S.; Ruscetti, F. W.; Pert, C. B.
  3. Current HIV Research. 2003 1(1): 51-67.
  1. 22.   Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2
  2. Kershaw, M. H.; Wang, G.; Westwood, J. A.; Pachynski, R. K.; Tiffany, H. L.; Marincola, F. M.; Wang, E.; Young, H. A.; Murphy, P. M.; Hwu, P.
  3. Human Gene Therapy. 2002 13(16): 1971-1980.
  1. 23.   MHC-I-restricted presentation of HIV-1 virion antigens without viral replication
  2. Buseyne, F.; Le Gall, S.; Boccaccio, C.; Abastado, J. P.; Lifson, J. D.; Arthur, L. O.; Riviere, Y.; Heard, J. M.; Schwartz, O.
  3. Nature Medicine. 2001 7(3): 344-349.
  1. 24.   Statistical estimation and pedigree analysis of CCR2-CCR5 haplotypes
  2. Clark, V. J.; Metheny, N.; Dean, M.; Peterson, R. J.
  3. Human Genetics. 2001 108(6): 484-493.
  1. 25.   Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 co-receptor and ligand binding function
  2. Howard, O. M. Z.; Shirakawa, A. K.; Turpin, J. A.; Maynard, A.; Tobin, G. J.; Carrington, M.; Oppenheim, J. J.; Dean, M.
  3. Journal of Biological Chemistry. 1999 274(23): 16228-16234.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel